Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT05938205
Eligibility Criteria:
Inclusion Criteria:
Participants will be included in the study based on the following inclusion criteria:
* Older men and women between 60-80 years
* The presence of sarcopenic obesity was considered when the following two conditions were satisfied: Fat mass \> 34.8% and FFM \<90% of subject's ideal FFM.
* Resident in Verona (Italy)
* Stable weight in the previous 2 months
* Previously sedentary (less than one hour of exercise per week in the last 6 months)
* Signing of the informed consent for participation in the study
Exclusion criteria:
* Unstable angina or recent myocardial infarction
* Malignant or unstable arrhythmias
* Heart failure NYHA class \> II
* Severe respiratory failure
* Severe heart valve disease (i.e severe aortic stenosis or insufficiency)
* Abdominal and/or thoracic aneurysm
* Recent intracerebral or subdural haemorrhage
* Poorly controlled arterial hypertension
* Presence of pacemakers or metal prostheses
* Severe chronic renal failure
* Symptomatic musculoskeletal pathology
* Symptomatic disc herniation, arthrosis, acute joint, tendon and ligamentous injuries, hip and/or knee prostheses recently placed (\<6 months) or with joint instability, symptomatic or large inguinal or abdominal hernia
* Acute retinal detachment or bleeding
* Recent eye surgery (laser, cataract, retinal surgery, glaucoma surgery)
* History of malignant cancer within the previous 5 years
* Diagnosis of dementia
* Eating disorders
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
80 Years
Study:
NCT05938205
Study Brief:
Protocol Section:
NCT05938205